FOXO3 is a transcription factor linked to longevity and cellular stress resistance. In animal models, FOXO3 has been shown to influence ovarian aging and potentially extend reproductive lifespan. In humans, observational studies have reported associations between certain FOXO3 variants and age at menopause or ovarian reserve markers, but the evidence is limited and inconsistent. The mechanistic plausibility is moderate, but human data are mostly from candidate gene or GWAS studies with small effect sizes. There are no clinical trials demonstrating that targeting FOXO3 improves fertility outcomes. Direct-to-consumer genetic tests that claim FOXO3 can predict or enhance fertility are overstating the evidence. Fertility decisions should be guided by clinical markers (e.g., AMH, antral follicle count) and medical history, not by single genetic variants. The evidence level for FOXO3 and fertility is currently mechanistic/unclear.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-b61c10c695cef335a13d63c2